Ultimo aggiornamento :
19/11/2024
Vitamina   Ascorbic acid  
Iniezione
Stabilità in soluzione Stabilità in miscela Fattori che influenzano la stabilità Compatibilità metodo di iniezione Bibliografia pdf
   Struttura chimica  

Nome commerciale   Nome commerciale     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acido ascorbico Chile, Colombia, Ecuador, Venezuela
Acmel Turchia
Adeene vitamina C Argentina
Amsac Messico
Ascorbic acid Australia, Emirati Arabi Uniti, Gran Bretagna, nuova Zelanda
Ascorbil Perù
Ascorbinezuur Paesi Bassi
Ascorell Germania
Ascorvit Germania
Bio C Perù
C Viton Egitto
Cebion Germania
Cemin Ecuador
Cevalin Messico
Cevarol Egitto
Cevitol Austria
Infalet Messico
Laperox Messico
Laroscorbine Francia, Marocco
Mega C acid Canada
Mel C Austria
Osve vitamin C Iran
Pascorbin Ecuador
Synum Germania
Viciforte Italia
Vitamedic Romania
Vitamin C Austria, Canada, Germania, Iran, Ungheria
Vitamina C Argentina, Colombia, Italia, Romania, Venezuela
Vitamine C Svizzera
Vitaminum C Polonia
Bibliografia   Iniezione   Bibliografia : Ascorbic acid  
tipo pubblicazione
319 Rivista Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
552 Rivista Martinez JF, Trissel LA, Gilbert DL.
Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
Int J Pharm Compound 1997 ; 1: 356-358.
939 Rivista Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170.
1057 Rivista Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1995 Rivista Chin A, Liu S, Ting-Chan J, Gill MA.
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Am J Health-Syst Pharm 2005 ; 62: 1073-1074.
3128 Laboratorio Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
Prostrakan 2013
3549 Laboratorio Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3588 Laboratorio Vancomycine (Vancocin®) - Résumé des caractéristiques du produit
Sandoz 2011
3646 Laboratorio Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2013
3674 Laboratorio Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3932 Laboratorio Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
4154 Laboratorio Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4245 poster Iazetta J, Law S, Adhikari NKJ, Lamontagne F, Kanji S, Walker SE.
Physical Compatibility and Stability of Ascorbic acid Injection in Polyvinyl Chloride Minibags at 4ºC and Room Temperature (25ºC).
2019
4471 Laboratorio Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
Kyowa Kirin Pharma 2019
4510 Rivista Stawny M, Gostyńska A, Olijarczyk R, Dettlaff K, Jelińska A, Ogrodowczyk M.
Stability studies of parenteral nutrition with a high dose of vitamin C.
J Oncol Pharm Practice 2020 ;26,8:1894–1902

  Mentions Légales